Skip to content

Clinical trials

Phase 1/2 Uterine Cervical Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uterine Cervical Neoplasms Phase: Phase 1/2 Country / region: China Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20161
20204
20211
20225
20237
20242
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting10
Terminated5
Active, not recruiting4
Unknown status4
Completed3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Evopoint Biosciences Inc.2
Fuda Cancer Hospital, Guangzhou2
Peking Union Medical College Hospital2
Shenzhen Geno-Immune Medical Institute2
Suzhou Zelgen Biopharmaceuticals Co.,Ltd2
AstraZeneca1
DualityBio Inc.1
Ensem Therapeutics1
Genmab1
Innolake Biopharm1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uterine Cervical Neoplasms26
Endometrial Neoplasms8
Ovarian Neoplasms7
Carcinoma, Non-Small-Cell Lung6
Breast Neoplasms5
Pancreatic Neoplasms4
Squamous Cell Carcinoma of Head and Neck4
Colorectal Neoplasms3
Head and Neck Neoplasms3
Prostatic Neoplasms3

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.